Dr. Mark Trolice underscores the harmful effects of vaping on fertility.

“There is a misconception that e-cigarettes are safe to use during pregnancy. Anyone on their fertility journey should avoid the use of nicotine altogether.”

ORLANDO, Fla. (PRWEB)
October 23, 2019

A study recently published in the Journal of the Endocrine Society suggests that women who use e-cigarettes may face difficulties in becoming pregnant, and that exposure to vaping could cause permanent health complications for the fetus [1]. Dr. Mark Trolice, Director of Fertility CARE: The IVF Center, notes that smoking regular cigarettes is already contraindicated for women seeking to become pregnant, and that vaping should be as well. “E-cigarettes are probably just as harmful to pregnancy and fertility as traditional cigarettes because they both have similar amounts of nicotine,” Dr. Trolice said. “There is a misconception that e-cigarettes are safe to use during pregnancy. Anyone on their fertility journey should avoid the use of nicotine altogether.”

In the new study, which was conducted by researchers at the University of North Carolina at Chapel Hill, mice were exposed to smoke from electronic cigarettes five times a week. This smoke exposure equaled the amount of smoke inhalation received by people who smoke e-cigarettes regularly. After four months of testing, researchers found that the exposed mice experienced what were described as significant delays in pregnancy and implantation [2].

Implantation, notes Dr. Trolice, is the first stage of pregnancy when the embryo adheres to the wall of the uterus and begins receiving oxygen and nutrients from the mother. The director of the new study indicated that while more research is needed, it seems likely that e-cigarette exposure in utero can cause lifelong changes to the fetal DNA and to fetal immune cardiovascular and nervous systems in mice [3].

These findings, says Dr. Trolice, come on the heels of a series of recent announcements of a mysterious and potentially fatal respiratory illness tied to vaping. As of mid-October, U.S. health officials had confirmed 33 deaths and 1,479 confirmed and probable cases so far. Kroger Company, Walgreens Boots Alliance Inc. and Walmart Inc. have said they would stop selling e-cigarettes in their stores, and the Chinese ecommerce firm Alibaba Group has announced that it will stop selling e-cigarette components in the United States [4].

“The journey to fertility,” says Dr. Trolice, “can be stressful, particularly for those who experience difficulty in conceiving. It is recommended to engage in healthy stress reduction activities such as exercise, yoga, and meditation – vaping is not one of them.”

“I strongly urge everyone—particularly those who might desire future childbearing—to stay away from vaping,” said Dr. Trolice. “It is a momentary fad that could ruin both your health, your opportunity to naturally conceive in the future and the health of your baby.”

About Fertility CARE: The IVF Center

Fertility CARE (Center of Assisted Reproduction and Endocrinology): The IVF Center provides patient-centered, evidence-based, and individual customized reproductive care in a comfortable and compassionate setting. Established in 2003 by Dr. Mark P. Trolice who is the founder, director as well as author of The Fertility Doctor’s Guide to Overcoming Infertility, This Central Florida IVF clinic consistently earns high patient ratings in online reviews is one of a select clinics in the country to offer both male and female testing, evaluation, treatment and psychological counselingi. Today, the practice encompasses the Center for Male Infertility, headed by a fellowship-trained male reproductive specialist; the Mind/Body Institute, overseen by a licensed clinical reproductive psychologist; and the IVF Laboratory of Central Florida, led by a Board-certified high complexity laboratory director. Fertility CARE – The IVF Center offers a comprehensive range of infertility tests and treatment options as well as genetic testing, egg freezing with fertility preservation, egg donation, embryo cryopreservation, gestational carrier and other services. For full details, visit http://TheIVFCenter.com.

About Dr. Mark P. Trolice

Mark P. Trolice, M.D., is the founder and Director of Fertility CARE – The IVF Center. He also serves as Associate Professor of Obstetrics and Gynecology (OB/GYN) at the University of Central Florida College of Medicine in Orlando and Medical Director of the Egg Donor Program at Cryos International, the world’s largest sperm donor bank. Dr. Trolice is Board-certified in OB/GYN and Reproductive Endocrinology and Infertility (REI), and he is a Fellow of the American Colleges of Obstetrics and Gynecology (FACOG), Surgeons (FACS), and Endocrinology (FACE). Renowned as Orlando’s most successful fertility specialist, Dr. Trolice and his wife battled infertility for over 10 years before adopting their children. This journey gave him unique insights into patients’ struggles and is included in his forthcoming book on infertility from Harvard Common Press. Dr. Trolice is a sought-after expert with dozens of broadcast and print appearances in addition to national acclaim as one of America’s Top Doctors® and repeat recipient of the American Medical Association’s “Physician’s Recognition Award”. In January 2019, he launched his “Fertility Health” podcast interviewing nationally renowned experts on vital topics in reproductive medicine. Learn why he has earned the trust of patients and physicians alike: http://marktrolicemd.com.

1.    Wetendorf, et al. “E-Cigarette Exposure Delays Implantation and Causes Reduced Weight Gain in Female Offspring Exposed In Utero.” OUP Academic, Oxford University Press, 5 Sept. 2019

2.    Fox, Eleanor Goulding, “The first evidence is emerging that vaping may negatively impact fertility,” Insider, September 13, 2019.

3.    Rosenfeld, Jordan, “Can vaping impair fertility?”, Medical Economics, October 7, 2019.

4.    Mulcahy, Lisa, “Need Another Reason To Stop Vaping? It May Keep You From Getting Pregnant,” Parade, September 12, 2019.

5.    Reuters, “Factbox: U.S. Vaping-Related Deaths Rise to 33,” New York Times, October 17, 2019.

###

Share article on social media or email:

Nanovis’ bioceramic nanotube surface on a Nano FortiCore interbody with a deeply porous interconnected titanium scaffold.

“We are delighted to receive such an important designation for this new class of nanotechnology. This nanotechnology plays an important role in achieving Nanovis’ goal to reduce the pain and suffering from implant loosening.”

CARMEL, Ind. (PRWEB)
October 23, 2019

Nanovis today announced that it received the first 510(k) clearance for a bioceramic nanotube surface that demonstrated the FDA requirements for nanotechnology.

“We are delighted to receive such an important designation for this new class of nanotechnology. This nanotechnology plays an important role in achieving Nanovis’ goal to reduce the pain and suffering from implant loosening. With this clearance we can rapidly apply this technology to our entire spinal implant portfolio so that we can help as many patients as possible and promote sales growth for the long-term,” says Nanovis CEO, Matt Hedrick.

Nanovis is an award-winning platform technology-driven growth company committed to helping surgeons and hospitals achieve excellent fixation and infection outcomes using advanced nanotechnology platforms. Its industry-leading fixation technologies offer surgeons and hospitals the best aspects of fixation, visualization, and durability. Nanovis’ developmental infection technology platforms promise to offer surgeons and hospitals much-needed bactericidal solutions.

Nanovis is actively expanding distribution for bioceramic nanotube enhanced Nano FortiCore interbodies. To discuss opportunities, please contact Jeff Shepherd, Vice President of Sales, at Jeff.Shepherd@NanovisTechnology.com.

About Nanovis

Nanovis discovers, develops, and commercializes innovative technology platforms designed for superior fixation and infection outcomes. Nanovis is commercializing the following innovative technology platforms: a bioceramic enhanced nanotube surface, a deeply porous titanium scaffold (licensed from Sites Medical), an advanced bioceramic bactericidal nanotube surface technology in pre-clinical studies, and a pre-clinical localized infection technology targeting anti-microbial resistant bacteria.

If you would like more information about Nanovis, please contact:

Guillaume Viallaneix

MedTech Momentum

(407) 960-2994

info@medtechmomentum.com

Share article on social media or email:

Xtalks Life Science Webinars

The RACE for Children Act is positioned to considerably change the regulatory landscape of oncology therapy development when it takes effect in August 2020.

TORONTO (PRWEB)
October 23, 2019

In this live webinar, Director of Regulatory Affairs at Medpace, David Horton, PhD and Lead Advanced Clinical Practitioner at Medpace, Peggy Kaiser, MSN, RN, PPCNP-BC, will guide participants through the impacts of the RACE for Children Act on the regulatory and clinical trial landscape.

This law focuses on the requirement for clinically meaningful evaluation of drugs directed at specific molecular targets relevant in pediatric cancer. Shifting the focus from indications to molecular targets, this law eliminates orphan exemptions for pediatric studies for oncology indications. The RACE for Children Act is positioned to considerably change the regulatory landscape of oncology therapy development when it takes effect in August 2020.

This webinar will take place on Wednesday, November 6, 2019 at 11am EST (4pm GMT/UK) and is open to VPs, Directors, Managers and Department Heads working within:

• 
      Clinical Affairs
•     Clinical Research
•     Clinical Pharmacology
•     Clinical Outsourcing
•     Project Management
•     Regulatory Affairs
•     Medical Affairs

Attendees will learn about:

• Regulatory – requirements of the RACE for Children Act and how this impacts your regulatory strategy and clinical development plans, including study designs
• Pediatric oncology trial management, operational challenges and considerations for efficient and accelerated execution

For more information or to register for this event, visit The RACE for Children Act Will Change the Landscape for Pediatric Cancer Research: Are you ready for August 2020?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

“…Customers First is one of our guiding principles at Medrio and I am thrilled we can leverage Christina’s extensive experience leading professional services organizations to fuel our next stage of growth.”

SAN FRANCISCO (PRWEB)
October 23, 2019

Medrio is pleased to announce the addition of Chief Operating Officer, Christina Hughes, to its executive leadership team.

As a market leader in solutions for EDC, Direct Data Capture and eCOA, Medrio’s integrated technology solutions allow growth-stage biotech and pharma companies to reduce timelines and improve quality with real-time data capture. In her role as COO, Christina will be responsible for developing a world class Customer Success organization focused on accelerating the delivery of Medrio’s technology solutions.

Christina brings over 20 years of experience in health care technology. She most recently was a Vice President at ERT, where she was responsible for ERT’s global service delivery organization across multiple service lines. Prior to ERT, Christina worked for AiCure and Bracket (now Signant Health) in sales and marketing, business development operations, and client services. Christina was named as one of PharmaVOICE’s top 100 most influential people in the life sciences industry in 2016.

“Christina brings tremendous experience and vision to our team and will be a great asset as we continue to scale our organization to meet the needs of our growth stage customers,” said Mike Novotny, founder and chief executive officer of Medrio. “Furthermore, Customers First is one of our guiding principles at Medrio and I am thrilled we can leverage Christina’s extensive experience leading professional services organizations to fuel our next stage of growth.”

“I am excited to join a company with a world-class technology platform like Medrio’s. I look forward to helping our clients accelerate their study timelines and maximize the value from Medrio’s solutions for Real World data capture,” commented Christina Hughes, regarding her new role as Medrio COO.

Christina holds a Master of Business Administration from the University of Pennsylvania’s The Wharton School and a Bachelor of Science from Yale University.

About Medrio

Medrio offers software-based eClinical solutions, providing clinical researchers with the tools necessary to accelerate research, eliminate hurdles, and maximize return on investment. Partnering with sponsors and CROs across all phases of research in pharma, biotech, medical device, and diagnostics, Medrio supports its clients along their journey to medical discovery.

Share article on social media or email:

Cimcor Logo

Earning a spot on this prestigious list further validated our vision to provide in-depth, real-time insight into all changes throughout the enterprise.

MERRILLVILLE, Ind. (PRWEB)
October 23, 2019

Cimcor, Inc, a global provider of security, integrity and compliance software solutions, has been named one of the “Hot 150 Cybersecurity Companies” to watch in 2020. The list is published by Cybersecurity Ventures, who evaluated Cimcor and its advanced file and system integrity monitoring software, CimTrak.

“Earning a spot on this prestigious list further validated our vision to provide in-depth, real-time insight into all changes throughout the enterprise,” says Robert E. Johnson, III, president and CEO of Cimcor, Inc. “Our focus has been, and will continue to be to help secure our customers with actionable intelligence, helping them to succeed in spite of the relentless pace of technological change and ever-growing threats.

Acknowledged as one of “the hottest and most innovative companies in the market focused exclusively or primarily on cybersecurity,” CimTrak’s next-gen file and system integrity monitoring software helps enterprises and government agencies not only detect unexpected changes and unauthorized modifications, but it can also help with the remediation process.

“Cimcor has been an innovator in the security, integrity and compliance software space since 1997, which makes them one of the longest standing pure-play companies on our list,” says Steve Morgan, founder and Editor-in-Chief for Cybercrime Magazine. “Their widely popular CimTrak Integrity Suite is used by a global customer base for change management, auditing, file integrity monitoring, and integrates with the leading SIEM solutions.”

List selection was based solely on merit and the criteria included: cybersecurity sector, feedback from CISOs, decision-makers, IT security evaluators and recommenders; founder and management pedigree; published product, technology and services reviews; demos and presentations at conferences; research, reports and surveys published; and more.

About Cimcor, Inc.

Cimcor, Inc. is an industry leader in developing innovative security, integrity and compliance software solutions. The firm is on the front lines of global corporate, government and military initiatives to protect critical IT infrastructure and has consistently brought IT integrity innovations to market. Cimcor’s flagship software product, CimTrak, helps organizations to monitor and protect a wide range of physical, network, virtual and cloud-based IT assets in real-time. For more information, visit https://www.cimcor.com/cimtrak.

About Cybercrime Magazine

The Hot 150 Cybersecurity Companies is published by Cybercrime Magazine and Cybersecurity Ventures, the world’s leading researcher and publisher of reports covering global cybercrime damage projections, cybersecurity spending forecasts, and cybersecurity employment figures.

Share article on social media or email:

Healthcare providers are learning that aggressive patient collection tactics damage their brands and alienate healthcare consumers

With patients on the hook for so much more of the cost, a provider’s reputation matters. Suing patients to collect from them and other aggressive collection tactics have no place in a business-building strategy. – Kevin Fleming, CEO, Loyale Healthcare

LAFAYETTE, Calif. (PRWEB)
October 23, 2019

In recent months, U.S. news media have been paying closer-than-usual attention to the ways hospitals bill and collect from patients. The issues range from surprise bills to overzealous collection methods that have gone so far as to seize paychecks and tax refunds – even claim homes. This scrutiny has fueled mounting public anger, prompting U.S. lawmakers to launch an investigation into provider billing practices. The focus of this anger has also expanded to include the private equity owners of some U.S. healthcare companies.

These forms of behavior turn the provider-patient relationship on its head – from care giver to financial adversary. Even more damaging, aggressive collection tactics frighten prospective patients. Concerned and uncertain about what they will owe and how they will pay for the care they need; many decide to skip care entirely. Research results vary on this topic, but the number of people who avoid or delay care because of concerns about their ability to afford it range from fifty percent to sixty-four percent.

There are two sides to this story. Healthcare providers are in a tough spot, too. They are expected to deliver exceptional clinical care and required to meet high regulatory standards. At the same time, they are struggling to collect from financially burdened patients with systems that were developed decades ago to collect from insurance companies. The solution to this problem, it seems, depends on providers’ willingness to abandon adversarial tactics and embrace a more personal, compassionate approach.

Healthcare in a Consumer-Driven Market: Brand Matters

You may have heard the expression, “there’s no such thing as bad publicity”, but ask any executive in an industry that relies on the good will of the buying public and they’ll tell you otherwise. Trusted companies like Disney, Apple, Nike and others spend untold millions in time and money to maintain, protect and grow brands that cultivate long-term consumer relationships. How these companies are perceived in the marketplace is fundamental to their continued success.

Healthcare now finds itself in a similar spot. When the insurance companies did most of the paying, a hospital’s brand was primarily clinical in nature and the financial experience didn’t matter that much. Patients chose the providers that were in their plan’s network, the provider delivered treatment and the payer paid. But now that patients are on the hook for so much more of the cost, they’re behaving differently. Suddenly, a provider’s reputation matters. In such an environment, suing patients to collect from them and other aggressive collection tactics have no place in a business building strategy.

Instead, more and more providers are developing consumer-centric, retail-like experiences. Recognizing that patient preference will be the principle driver of volume and revenue, they’re reimagining the patient experience from new, much larger perspectives. HCA Healthcare is one example. One of the largest and most successful healthcare brands in America, HCA is focused on constantly improving the patient’s financial journey.

Loyale Healthcare has partnered with over 12,000 healthcare facility customers representing in excess of $50 Billion in annual net patient revenue and forty million patient encounters. With a focus on delivering end-to-end functionality, our solution supports six key patient financial elements, all of which contribute to improved patient financial experiences and provider brand value:

1.    Price transparency – One of the biggest problems facing the healthcare industry’s transition into a consumer-first operating model is its pervasive inability to provide patients with reliable upfront estimates for care. In every other purchase decision we consumers make, price is one of the most important considerations. Until now, healthcare has been exempt, but those days are numbered. The government and powerful new competitors like Haven Healthcare, CVS Health and others will see to that.

2.    Payment planning – When a patient knows early what their care is likely to cost, and how much their out-of-pocket will be, they can plan for the expense. With Loyale’s Affordability Workbench™, patients have access to multiple payment options that include discounts for early or prompt payment; short-term, no interest payment schedules; or longer-term payment plans through a third-party lender. Serving themselves online, or working with hospital staff, patients can get the care they need while focusing on payments they can afford, not just worrying about what they’ll owe.

3.    Personalized digital & human communications – Patients are often slow to react to traditional hospital billing communications. Whether sent by mail, email or online over the hospital’s patient portal, form letters do nothing to engage patients or provide the clarity they need to understand and act on their financial obligations. Loyale’s personalized digital communication platform, on the other hand, automatically segments patient populations. By integrating with patient preferences, we then deliver the right messages at the right frequency over the right channel – email, text, chat or by initiating a human conversation.

4.    One Bed. One Bill – Ask most patients and they’ll tell you… they’re confused, frustrated and angry about their healthcare bills. “It was one stay in one bed for one thing. Why did I get eleven bills?” With the Loyale platform, Providers can now consolidate bills into one, comprehensive virtual “bill” presentation that patients can understand and act on. Loyale’s underlying technology takes care of making sure the payments get where they need to go.

5.    Seamless, holistic experiences – Healthcare has long separated patient experiences into two different categories; the clinical and the administrative/financial. But patients will tell you that they have just one care experience, and that experience includes every interaction the patient has with the provider, every time. That’s why Loyale integrates with the Provider’s clinical portal. Additionally, its provider-facing portal gives hospital staff and call centers the patient’s account view for easy problem solving.

6.    Provider facing tools to improve productivity and increase revenues – Beginning well before treatment, the Loyale patient financial engagement platform collects and aggregates data to qualify patients. Then the system automatically generates intelligent workflows that reduce staff work and improve the probability of patient payment. Additionally, the tool’s highly configurable reporting and dashboard functionality is now giving health systems the “best visibility into patient-pay revenue cycle they have ever had”. This invaluable business intelligence is making it possible for leadership to find and promote best practices and tackle underperforming practices.

By delivering patient-first financial experiences, healthcare providers across the country are finding that patients are eager to engage. This leads to dramatic increases in patient self-service, reduced costs for traditional paper billing and collections and higher patient-pay revenue. Best of all, it responds to patient expectations for transparency, clarity and inclusion. By partnering with them in the financial dimension of care, healthcare can now provide patients and their communities with healthcare financial experiences they can understand and control.

Kevin Fleming is the CEO of Loyale Healthcare

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale recently announced an Enterprise level strategic partnership with Parallon including deployment of its industry leading technology to all HCA hospitals and Physician Groups.

Pivot Point Consulting invests in top notch healthcare IT leaders who bring decades of practical strategy and implementation experience to deliver value for both today’s and tomorrow’s opportunities.

NASHVILLE, Tenn. (PRWEB)
October 23, 2019

Pivot Point Consulting, a Vaco Company, continues to invest in a differentiated experience for clients and consultants, as well as advisory services with the recent additions of Mauraan Schultz, Vice President, Delivery, and Joe Clemons, Director, Advisory Services.

Schultz started her career in pharmacy operations and moved on to work with firms including Ernst & Young, Accenture, McKesson and several dot coms. With 20+ years of healthcare IT experience in digital health and customer experience leading implementations and strategic projects, she will drive delivery excellence with clients and consultants.

“Pivot Point Consulting has a “customer first” mentality. With the rise of consumerism in healthcare, now, more than ever, healthcare organizations have an opportunistic moment to guide their staff to embrace change and incorporate retail and ecommerce technologies. It’s is exciting to be a leader in this transformational time,” said Schultz.

In addition, Joe Clemons joined the Advisory services team as an experienced healthcare leader who has successfully managed projects and multi-disciplinary teams across clinical, business, financial and technical operations functions with system selection, implementation and post-live support. Clemons also started his career in pharmacy management and pivoted to healthcare IT, where he led many EHR and pharmacy system implementations, served as the ICD-10 program manager for a large health system and managed Workday HRIS/ERP system implementations.

“Pivot Point Consulting invests in top notch healthcare IT leaders who bring decades of practical strategy and implementation experience to deliver value for both today’s and tomorrow’s opportunities.” – Rachel Marano, Managing Partner & Co-Founder.

About Pivot Point Consulting

Pivot Point Consulting enables healthcare organizations to realize the most value from their technology and data through their KLAS ranked advisory, implementation/optimization, managed services and talent solutions.

The company provides strategy and consulting services for providers, payers and life sciences organizations – with roughly 400 consultants serving 85+ clients across the United States. Pivot Point Consulting has earned many industry and workplace quality awards including: Top three Best in KLAS for HIT Implementation and Support for four years running (2015, 2016, 2017 and 2018), Highest Rated Vendor in KLAS Implementation Services in the Select Category (July 2017), #1 in KLAS for Epic Consulting in the Select Category (2016), #9 in Modern Healthcare’s Best Places to Work in 2016.

For more information about Pivot Point Consulting, visit http://www.pivotpointconsulting.com. Follow us on LinkedIn.

Share article on social media or email:

The alliance will not only allow us to offer more value to our readers through a greater breadth of information on ACCC activities and research, but will also increase ACCC’s visibility and impact in the oncology and value-based care fields.

MALVERN, Pa. (PRWEB)
October 22, 2019

HMP, a leader in health care events and education, today announced that its peer-reviewed publication, Journal of Clinical Pathways®, has formed a strategic partnership with the Association of Community Cancer Centers (ACCC), a leading education and advocacy organization for the cancer care community.

Through this alliance, readers of the journal will benefit greatly from regular columns from ACCC and its membership on topics such as multidisciplinary approaches to care delivery, reimbursement issues, trends in cancer care, the evolving practice of oncology pharmacy, and integrating new technologies and therapies into practice. In addition, ACCC will gain significant reach to more value-based cancer care decision-makers through the journal’s robust print and digital distribution channels.

“We are very pleased to collaborate with ACCC,” said Kara A. Rosania, MSc, Senior Editorial Director, Oncology and Managed Markets Divisions, HMP. “The alliance will not only allow us to offer more value to our readers through a greater breadth of information on ACCC activities and research, but will also increase ACCC’s visibility and impact in the oncology and value-based care fields.”

ACCC has added Linda Frisk, PharmD, Clinical Pharmacist at Ironwood Cancer & Research Centers (Chandler, AZ), and member of the leadership team for the National Community Oncology Dispensing Association Inc., to the journal’s editorial advisory board. Dr. Frisk will provide the journal with expert guidance on the changing landscape of value-based cancer care and reimbursement models.

“ACCC is pleased to collaborate with Journal of Clinical Pathways to advance the critical conversation on defining and demonstrating value in cancer care and to help promote innovative strategies to accomplish this,” said Leigh Boehmer, PharmD, BCOP, Medical Director, ACCC. “Through this partnership, we aim to increase our reach to value-based oncology care decision-makers and reduce current health system silos that can hinder innovative collaborations aimed at providing high-quality oncology services to patients.”

About Journal of Clinical Pathways

Founded in 2015, Journal of Clinical Pathways captures the shift in health care away from a fee-for-service system and toward a value-based care delivery and reimbursement model. The move towards value-based medicine combined with innovations in big data has brought clinical pathways to the forefront as a means to drive precision and optimization of care for patients. Journal of Clinical Pathways addresses the potential of clinical pathways to address rising health care costs, mitigate patient risk, reduce variability, and achieve better, more predictable clinical outcomes. In this unique publication, physicians, payers, and health care executives share methods, insights, and results of projects to design, implement, evaluate, and update clinical pathways in their organizations. Journal of Clinical Pathways is specifically positioned to address the design and implementation of value-based care approaches; the use of clinical and real-world evidence to drive treatment decision-making; and the early learnings and experiences of managed care professionals and health care organizations as they implement new models for achieving high-value care. To learn more, visit journalofclinicalpathways.com.

About HMP

HMP is the force behind Healthcare Made Practical – and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

About the Association of Community Cancer Centers

The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 25,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve, so does ACCC, adapting its resources to meet the changing needs of the entire oncology care team. For more information, visit accc-cancer.org.

Share article on social media or email: